Literature DB >> 6788700

Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

O R Pavlovskis, D C Edman, S H Leppla, B Wretlind, L R Lewis, K E Martin.   

Abstract

The immunoprophylactic effect of chemically inactivated Pseudomonas aeruginosa exotoxin A in experimental pseudomonas infections was studied. Exotoxin A toxoids were prepared by Formalin (f-TXD) or glutaraldehyde (g-TXD) treatment. Immunization of mice with three or four doses (10 micrograms each) of f-TXD and the synthetic adjuvant N-acetylmuramyl-L-alanyl-D-isoglutamine (50 micrograms) induced high levels of antiexotoxin A antibodies as measured by passive hemagglutination assay and enzyme-linked immunosorbent assay. Immunization with toxoid alone did not elicit antitoxin. A significant increase in survival time and survival rate (P less than 0.01) was seen in immunized (f-TXD) and in burned and infected mice (50 to 85%) as compared with control mice immunized with formalinized bovine serum albumin (6 to 20%). Virtually 100% survival was obtained when preinfection immunization weas combined with single-dose gentamicin treatment within 24 h of infection. Immunization with g-TXD increased survival time (P less than 0.01) but did not consistently increase survival rate, and the results were not as satisfactory as those with formalinized exotoxin. The data presented indicate that active immunization with formalinized exotoxin A toxoid and adjuvant induced protective immunity to various degrees against infections in mice and could be potentially useful in prophylaxis of P. aeruginosa infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788700      PMCID: PMC351501          DOI: 10.1128/iai.32.2.681-689.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  41 in total

Review 1.  Extracellular toxins of Pseudomonas aeruginosa.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

Review 2.  Pseudomonas aeruginosa infections.

Authors:  L S Young; D Armstrong
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1972-09

3.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

4.  Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin.

Authors:  I A Holder; M Jogan
Journal:  J Trauma       Date:  1971-12

5.  Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.

Authors:  S Hanessian; W Regan; D Watson; T H Haskell
Journal:  Nat New Biol       Date:  1971-02-17

6.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

7.  Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A.

Authors:  P V Liu; S Yoshii; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

8.  Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.

Authors:  P V Liu; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

9.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

10.  Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins.

Authors:  R C Knudsen; L T Callahan; A Ahmed; K W Sell
Journal:  Appl Microbiol       Date:  1974-08
View more
  15 in total

1.  Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.

Authors:  H Müller; C Kettelhack; M Kettelhack; H G Sonntag; G Keilich; R Brossmer; J Richards; V Kinzel; E Bäuerlein; H Pech
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Pseudomonas aeruginosa immunotherapy.

Authors:  J E Pennington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

Review 3.  New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections.

Authors:  S J Cryz
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

4.  Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa.

Authors:  M J Rosok; M R Stebbins; K Connelly; M E Lostrom; A W Siadak
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation.

Authors:  A M Hooke; P J Arroyo; M P Oeschger; J A Bellanti
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant.

Authors:  D O Sordelli; M C Cerquetti; A M Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells.

Authors:  Jennifer C Hsieh; Doris M Tham; Weijun Feng; Fan Huang; Selamawit Embaie; Keyi Liu; Deborah Dean; Ralf Hertle; David J Fitzgerald; Randall J Mrsny
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.609

9.  Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.

Authors:  Ali Manafi; Jamshid Kohanteb; Davood Mehrabani; Aziz Japoni; Masoud Amini; Mohsen Naghmachi; Ahmad Hosseinzadeh Zaghi; Nazanin Khalili
Journal:  BMC Microbiol       Date:  2009-02-01       Impact factor: 4.465

10.  Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.

Authors:  K W Klinger; C W Shuster; J Klinger
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.